Smartee's Manufacturing Partnership with Straumann Signals Clear Aligner Consolidation
Event summary
- Smartee Denti-Technology reached 100,000 cases utilizing its GS Mandibular Repositioning technology in 2025.
- The company launched a 100,000-square-meter intelligent manufacturing campus to expand production capacity.
- Smartee entered a strategic partnership with Straumann Group to provide manufacturing support for ClearCorrect in EMEA and APAC markets.
- Smartee introduced two new technologies: Smartee Sleep Aligner (for sleep apnea) and Smartee Live 3D (an AI-powered treatment planning tool).
The big picture
Smartee's rapid expansion and strategic partnership with Straumann indicate a maturing market for digital orthodontics. The company’s focus on clinical validation and manufacturing scale-up positions it to capitalize on the growing demand for clear aligner solutions, but also introduces complexities in managing a larger, more geographically diverse operation. The partnership with Straumann, a major player in dental implant technology, suggests a broader trend of integration within the dental device ecosystem.
What we're watching
- Market Dynamics
- The Straumann partnership suggests a potential shift towards consolidation within the clear aligner market, as larger players seek to leverage specialized manufacturing capabilities.
- Clinical Adoption
- The continued publication of research validating Smartee’s mandibular repositioning protocols will be critical for driving broader adoption among orthodontists and influencing reimbursement policies.
- Execution Risk
- Smartee’s ability to effectively manage the increased production volume and maintain product consistency while supporting Straumann’s ClearCorrect brand will be a key determinant of future success.
Related topics